Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate.
about
Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions for therapy.Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.Timing of ICAM-I Expression in a Canine Model of Post-Haemorrhagic Cerebral Vasospasm.Nitric oxide in cerebral vasospasm: theories, measurement, and treatment.Transdermal nitroglycerin in patients with subarachnoid hemorrhage.Effects of nitric oxide and noradrenergic activation in the posterior hypothalamus on arterial pressure tolerance to nitroglycerin in rats.
P2860
Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Intravenous nitroglycerin for ...... soconstriction in the primate.
@en
Intravenous nitroglycerin for ...... soconstriction in the primate.
@nl
type
label
Intravenous nitroglycerin for ...... soconstriction in the primate.
@en
Intravenous nitroglycerin for ...... soconstriction in the primate.
@nl
prefLabel
Intravenous nitroglycerin for ...... soconstriction in the primate.
@en
Intravenous nitroglycerin for ...... soconstriction in the primate.
@nl
P2093
P1476
Intravenous nitroglycerin for ...... soconstriction in the primate.
@en
P2093
P304
P356
10.3171/JNS.1981.55.6.0865
P407
P577
1981-12-01T00:00:00Z